Host response targeting of both immune and stromal components, represents a game changing opportunity to overcome cancer through the body's built in defense mechanisms. Our focus in this application is to exploit the host response through nano approaches for cancer disease management and treatment. We propose developing targeted methods for the delivery of biologics and, immunologic- modifiers and chemotherapies against melanoma and non-small cell lung cancers (NSCLC), utilizing innovative nanotechnologies developed here at UNC-Chapel Hill. We have proposed four projects in this proposal. The projects revolve around the central theme of exploiting the host response against tumors with an emphasis on the immune response. Project 1 is the designated basic science project since novel polymetformin nanoparticles are being proposed for more efficient and effective delivery of siRNA, which is a critical challenge for drug delivery The project targets Vemurafenib resistant melanoma, and emphasizes direct suppression of drug resistance that is coupled with a new vaccine approach. Project 2 evaluates ways to enhance the anti-tumor immune response through novel delivery of antigens via Particle Replication in Non-wetting Templates (PRINT(r)) nanoparticles. Unique adjuvants, such as Pathogen-associated Molecular Patterns, are being explored as well as the active suppression of blockers of host immunity in melanoma. Project 3 takes advantage of the biology of antigen release and the abscopal effect post irradiation through specifically designed nanoparticles to enhance antigen capture and the immune response to both primary tumors and metastases in melanoma. Project 4 uses polymeric micelles with high capacity loading to deliver therapeutics targeted to the tumor microenvironment as well as tumor cells in NSCLC. In summary, our Carolina CCNE is focused on improving cancer disease control and management to enhance treatment options for patients by the use of novel nanoparticles used in innovative ways that should have impact far beyond the specific disease conditions that are being studied.
The central theme of this application is to exploit the host response through nano approaches for cancer disease management and treatment. We propose developing targeted methods for the delivery of biologics, immunologic- modifiers and chemotherapies against melanoma and non-small cell lung cancers, utilizing innovative nanotechnologies developed here at UNC- Chapel Hill.
|Liu, Qi; Zhu, Hongda; Liu, Yun et al. (2017) BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma. Cancer Immunol Immunother :|
|Tian, Jing; Min, Yuanzeng; Rodgers, Zachary et al. (2017) Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models. J Mater Chem B 5:6049-6057|
|Min, Yuanzeng; Roche, Kyle C; Tian, Shaomin et al. (2017) Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. Nat Nanotechnol 12:877-882|
|Cheng, Lifang; Wang, Yuhua; Huang, Leaf (2017) Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node. Mol Ther 25:1665-1675|
|Tian, Jing; Min, Yuangzeng; Rodgers, Zachary et al. (2017) Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer. Nanomedicine 13:1301-1307|
|Tian, Xi; Nguyen, Minh; Foote, Henry P et al. (2017) CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1?. Cancer Res 77:112-122|
|Perry, Jillian L; Reuter, Kevin G; Luft, J Christopher et al. (2017) Mediating Passive Tumor Accumulation through Particle Size, Tumor Type, and Location. Nano Lett 17:2879-2886|
|Song, Wantong; Musetti, Sara N; Huang, Leaf (2017) Nanomaterials for cancer immunotherapy. Biomaterials 148:16-30|
|Qiu, Hui; Min, Yuanzeng; Rodgers, Zach et al. (2017) Nanomedicine approaches to improve cancer immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 9:|
|Haynes, Matthew T; Huang, Leaf (2016) Multistage Delivery Technologies: Multifunctional, Interdisciplinary Approaches to Nanomedicine. Mol Ther 24:849-51|
Showing the most recent 10 out of 29 publications